| Members |
targetComponentId |
| diskografi vha. røntgengennemlysning |
Fluoroscopic discography with injection of contrast into intervertebral disc |
| diskografi vha. røntgengennemlysning af lænderygsøjlen |
Fluoroscopic discography with injection of contrast into intervertebral disc of lumbar spine |
| Fluoroscopic lymphangiogram |
Fluoroscopic lymphangiography with contrast (procedure) |
| lymfangiografi vha. røntgengennemlysning af overekstremitet |
Fluoroscopic lymphangiography of upper limb with contrast (procedure) |
| fluoroskopimonitorering og radiografi ved indsættelse af pacemaker |
Fluoroscopy guided insertion of cardiac pacemaker with contrast |
| pouchografi vha. røntgengennemlysning |
Fluoroscopy of ileal pouch with contrast (procedure) |
| vasografi vha. røntgengennemlysning |
Fluoroscopy of vas deferens with contrast (procedure) |
| Fluoroscopy NOS |
Fluoroscopy |
| Fluoroscopy NOS |
Fluoroscopy |
| Fluoroscopy and radiography - brain |
Fluoroscopy - brain |
| røntgengennemlysning og radiografi af hjernen |
Fluoroscopy - brain |
| Fluoroscopy and radiography - digestive |
Digestive system fluoroscopy |
| røntgengennemlysning og radiografi af fordøjelsessystemet |
Digestive system fluoroscopy |
| røntgengennemlysning af hjertet mhp. kontrol af elektrodeposition af kardiel pacemaker |
Cardiac fluoroscopy |
| røntgengennemlysning af hjertet mhp. kontrol af position af permanent pacemaker |
Cardiac fluoroscopy |
| Fluoroscopy of heart for checking of position of cardiac monitoring implant position |
Cardiac fluoroscopy |
| fluoruracil 1 % opløsning |
Product containing only fluorouracil (medicinal product) |
| fluorouracil 5 % opløsning |
Product containing only fluorouracil (medicinal product) |
| fluorouracil 50 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
Fluorouracil (as fluorouracil sodium) 50 mg/mL solution for injection |
| allergi over for flupentixoldecanoat |
Allergy to flupentixol |
| allergi over for fluphenazindecanoat |
Allergy to fluphenazine (finding) |
| allergi over for fluophenazinenanthat |
Allergy to fluphenazine (finding) |
| Flurbiprofen sodium 0.03% conventional release eye drops |
Product containing precisely flurbiprofen sodium 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| flurbiprofennatrium 0,03 % øjendråber til engangsbrug |
Product containing precisely flurbiprofen sodium 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Flushing of Hickman line |
Flushing of central line |
| skylning af Hickman-kateter |
Flushing of central line |
| Flushing of Port-a-cath |
Flushing of implantable venous access port |
| Flushing of Port-a-cath |
Flushing of implantable venous access port |
| skylning af Port-a-cath |
Flushing of implantable venous access port |
| fluticasonpropionat 0,5 mg/2 ml nebulisatorampul |
Fluticasone propionate 250 microgram/mL solution for inhalation |
| Fluticasone propionate 110mcg aerosol |
Fluticasone only product in pulmonary dose form |
| Fluticasone propionate 110mcg powder for inhalation |
Fluticasone only product in pulmonary dose form |
| fluticasonpropionat 110 µg inhalation aerosol |
Fluticasone only product in pulmonary dose form |
| Fluticasone propionate 110mcg/spray aerosol |
Fluticasone only product in pulmonary dose form |
| Fluticasone propionate 125mcg/spr inhalant |
Fluticasone only product in pulmonary dose form |
| fluticasonpropionat 125 µg inhalator |
Fluticasone only product in pulmonary dose form |
| Fluticasone propionate 220mcg aerosol |
Fluticasone only product in pulmonary dose form |
| fluticasonpropionat 220 µg inhalation aerosol |
Fluticasone only product in pulmonary dose form |
| Fluticasone propionate 220mcg/spray aerosol |
Fluticasone only product in pulmonary dose form |
| Fluticasone propionate 250mcg/spr inhalant |
Fluticasone only product in pulmonary dose form |
| fluticasonpropionat 250 µg inhalator |
Fluticasone only product in pulmonary dose form |
| fluticasonpropionat 2 mg/2 ml nebulisatorampul |
Fluticasone propionate 1 mg/mL solution for inhalation |
| Fluticasone propionate 44mcg aerosol |
Fluticasone only product in pulmonary dose form |
| fluticasonpropionat 44 µg inhalation aerosol |
Fluticasone only product in pulmonary dose form |
| Fluticasone propionate 44mcg/inh aerosol |
Fluticasone only product in pulmonary dose form |
| Fluticasone propionate 50mcg/spr inhalant |
Fluticasone only product in pulmonary dose form |
| fluticasonpropionat 50 µg inhalator |
Fluticasone only product in pulmonary dose form |
| Fluvastatin sodium 20mg capsule |
Product containing precisely fluvastatin (as fluvastatin sodium) 20 milligram/1 each conventional release oral capsule (clinical drug) |
| Fluvastatin sodium 40mg capsule |
Product containing precisely fluvastatin (as fluvastatin sodium) 40 milligram/1 each conventional release oral capsule (clinical drug) |
| Fluvoxamine 100mg extended release capsule |
Fluvoxamine maleate 100 mg prolonged-release oral capsule |
| Fluvoxamine 150mg extended release capsule |
Product containing precisely fluvoxamine maleate 150 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Fokal episodisk, unilateral spike wave, tre spike waves per sekund |
Focal episodic spike wave |
| Focal seizure with experiential sensory symptoms |
An epileptic seizure originating within networks limited to one hemisphere, in which the initial manifestation is non-motor (including autonomic, behavior arrest, cognitive, emotional, or sensory onsets), regardless of whether aware or with impaired awareness. |
| Folic acid 300micrograms/5mL conventional release oral syrup |
Folic acid only product in oral dose form |
| folsyre 300 µg/5 ml sukkerfri syrup |
Folic acid only product in oral dose form |
| Folic acid 4mg/5mL conventional release oral syrup |
Folic acid 800 microgram/mL oral solution |
| folsyre 4 mg/5 ml sukkerfri syrup |
Folic acid 800 microgram/mL oral solution |
| Folic acid 5mg/5mL conventional release oral syrup |
Product containing precisely folic acid 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
| folsyre 5 mg/5 ml sukkerfri syrup |
Product containing precisely folic acid 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Folie a deux |
Induced psychotic disorder |
| folinsyre 100 mg/2 ml injektionsvæske |
Product containing only folinic acid (medicinal product) |
| Folinic acid 15mg injection |
Product containing only folinic acid (medicinal product) |
| Folinic acid 15mg injection |
Product containing only folinic acid (medicinal product) |
| folinsyre 15 mg pulver til injektionsvæske, opløsning, hætteglas |
Product containing only folinic acid (medicinal product) |
| folinsyre 30 mg pulver til injektionsvæske, opløsning, hætteglas |
Product containing only folinic acid (medicinal product) |
| folinsyre 400 mg/8 ml injektionsvæske |
Product containing only folinic acid (medicinal product) |
| Folinic acid 50mg/mL injection solution 18mL vial |
Product containing only folinic acid (medicinal product) |
| Folinic acid 50mg/mL injection solution 8mL vial |
Product containing only folinic acid (medicinal product) |
| folinsyre 900 mg/18 ml injektionsvæske |
Product containing only folinic acid (medicinal product) |
| Follicle stimulating hormone releasing factor preparation |
Product containing gonadotropin releasing factor (product) |
| follikulært centercelle-B-celle-lymfom (nodalt/systemisk med hudinvolvering) |
Malignant lymphoma, follicular center cell |
| Folliculitis ulerythematosa reticulata |
Atrophoderma vermiculatum |
| Follitropin recombinant + luteinizing hormone + sodium chloride 75unt/75unt/9%wv injection |
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
| Follow-up arranged NOS |
Follow-up arranged (finding) |
| Follow-up arranged NOS |
Follow-up arranged (finding) |
| opfølgende osteoporosevurdering |
Assessment of osteoporosis (procedure) |
| Follow-up osteoporosis assessment |
Assessment of osteoporosis (procedure) |
| Follow-up osteoporosis assessment |
Assessment of osteoporosis (procedure) |
| Follow-up refused |
Follow-up encounter declined (situation) |
| opfølgning afslået |
Follow-up encounter declined (situation) |
| Food AND/OR beverage |
Edible substance (substance) |
| Food dispenser NOS |
Food dispenser |
| Food dispenser NOS |
Food dispenser |
| Food mix RAST test |
Food mix specific IgE antibody measurement |
| Food mix RAST test |
Food mix specific IgE antibody measurement |
| fødevareblanding-rasttest |
Food mix specific IgE antibody measurement |
| Food poisoning due to other Clostridia |
Food poisoning caused by Clostridia |
| Food processor NOS |
Food and drink processor |
| Food processor NOS |
Food and drink processor |
| Foodball |
Phytobezoar |
| Foot X-ray |
Plain X-ray of foot |
| røntgenundersøgelse af fod, ortopædisk/biomekanisk undersøgelse |
Plain X-ray of foot |
| Foot flap |
Flap (substance) |
| Foot random pattern flap |
Random pattern flap |
| røntgenundersøgelse af bløddele i fod |
Plain X-ray of soft tissue of foot |
| Foot sprain NOS |
Sprain of foot |
| distorsion i fod, ikke nærmere specificeret |
Sprain of foot |
| Forces sick on leave cert NOS |
Forces sickness on leave certification status |
| Forces sick on leave cert NOS |
Forces sickness on leave certification status |
| forceret korrektion af deformitet, ikke nærmere specificeret |
Forcible deformity correction |
| Forcible deformity correction NOS |
Forcible deformity correction |
FHIR